-
-
-
-
-
-
-
Roche Completes Acquisition of Telavant from Roivant, Including Rights to Novel TL1A Directed Antibody (RVT-3101) for the Treatment of Inflammatory Bowel Disease
-
-
-
-
-
-
-
Promedior Announces Completion of Acquisition by Roche
-
-
-
-
-
-
-
PDQ Announces Advanced Transaction Analytics For Its ATS Based on Paradigm4's SciDB
-
-
-
-
-
-
1,122,779 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

